Netgear Inc. (NASDAQ:NTGR) shares advanced 2.19% in last trading session and ended the day at $37.37. NTGR Gross Margin is 28.10% and its has a return on assets of -1.40%. Netgear Inc. (NASDAQ:NTGR) quarterly performance is -10.32%.
On 20 January, NETGEAR®, Inc. (NASDAQ: NTGR) announced the appointment of Grady Summers to its board of directors. Mr. Summers brings extensive experience in technology trends, cybersecurity and cloud-based products and services in a variety of highly relevant global technology companies and industries. He fills a newly created seat on NETGEAR’s board of directors and has been appointed as a member of the audit committee of the board as well. Mr. Summers will stand for election at NETGEAR’s next annual stockholder meeting to be held later in 2016, when it is anticipated that the board size will return to nine as a result of the departure of a retiring director.
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) ended the last trading day at $3.23. Company weekly volatility is calculated as 7.87% and price to cash ratio as 2.31. Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) showed a weekly performance of -2.42%.
On 29 January, Pzena Investment Management, Inc (NYSE:PZN) shares advanced 3.63% and was closed at $7.70. PZN EPS growth in last 5 year was 13.60%. Pzena Investment Management, Inc (NYSE:PZN) year to date (YTD) performance is -10.47%.
Pzena Investment Management, Inc. (NSYE:PZN) announced that it will hold a conference call to discuss the Company’s financial results and outlook at 10:00 a.m. ET, Wednesday, February 10, 2016. The call will be open to the public.
Nektar Therapeutics (NASDAQ:NKTR) shares fell -0.51% in last trading session and ended the day at $13.64. NKTR Gross Margin is 84.80% and its has a return on assets of -15.80%. Nektar Therapeutics (NASDAQ:NKTR) quarterly performance is 10.98%.
Janney Montgomery Scott began coverage on shares of Nektar Therapeutics (NASDAQ:NKTR) in a report issued on Wednesday, The Fly reports. The brokerage set a “buy” rating on the biopharmaceutical company’s stock.
Mellanox Technologies, Ltd. (NASDAQ:MLNX) caters to the Technology space. It has a net profit margin of 7.30% and weekly performance is 17.02%. On the last day of trading company shares ended up at $45.45.
Mellanox® Technologies, Ltd. (NASDAQ: MLNX) announced financial results for its fourth quarter and fiscal year ended December 31, 2015. Revenues were $176.9 million in the fourth quarter, and $658.1 million in fiscal year 2015. GAAP gross margins were 70.7 percent in the fourth quarter, and 71.3 percent in fiscal year 2015. Non-GAAP gross margins were 72.2 percent in the fourth quarter, and 72.8 percent in fiscal year 2015. GAAP operating income was $19.9 million, or 11.3 percent of revenue, in the fourth quarter, and operating income was $75.1 million, or 11.4 percent of revenue, in fiscal year 2015.
Leave a Reply